The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...] …
Category: Pharma Industry
A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...] …
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...] …
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...] …
Two major drugmakers recently filed lawsuits challenging Maine’s new 340B contract pharmacy access law, drawing sharp criticism from an influential [...] …
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...] …
The number of drugmakers that have placed 340B contract pharmacy restrictions on health centers has more than doubled since the [...] …
Two large pharmaceutical companies this week filed the first federal lawsuits challenging Rhode Island’s recently enacted 340B contract pharmacy access [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...] …